Új, epicutan módszer az allergia oki kezelésére
Keyword(s):
Abstract: The only causal treatment for the allergic diseases is the allergen immunotherapy. Besides oral and injection forms, an epicutaneous form is known as well. During the immunization process the use of an adjuvant material is advisable besides the allergen. That adjuvant material can be (besides of the aluminium hydroxid and tyrosine) a bacterial toxin, too. In idealistic circumstances we can substitute the native allergen with its recombinant variant, which could keep its immunogenicity but had lost the allergenicity. In the future the recommended therapy could be the safe, painless, epicutaneous hyposensitization, with recombinant allergens, with bacterial toxin as adjuvants. Orv Hetil. 2017; 158(23): 895–899.
2020 ◽
Vol 21
(2)
◽
pp. 153-158
◽
Keyword(s):
1998 ◽
Vol 102
(4)
◽
pp. 558-562
◽
2016 ◽
Vol 65
(3)
◽
pp. 243-252
◽
2012 ◽
Vol 2012
◽
pp. 1-13
◽
2011 ◽
Vol 127
(4)
◽
pp. 860-864
◽
2016 ◽
Vol 137
(2)
◽
pp. 351-357
◽
2021 ◽
Keyword(s):